Home » Topics » BioWorld Science

BioWorld Science
RSS

Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical patent TLR7/8/9 antagonists

June 23, 2022

Katholieke Universiteit Leuven describes new TRPM3 antagonists

June 23, 2022

Roche synthesizes new HBV HBsAg and HBeAg inhibitors

June 23, 2022

New P2X purinoceptor 3 antagonists discovered at Chiesi

June 23, 2022

Biodistribution and efficacy of [177Lu]rhPSMA-10.1 compared to [177Lu]PSMA-I&T in prostate cancer

June 23, 2022

EGFRvIII T-cell bispecific antibody activity in glioblastoma models

June 23, 2022

Study rekindles hope for exercise pill -- or at least, molecular exercise science

June 22, 2022

NLRP11 identified as an essential component of the NLRP3 inflammasome in human macrophages

June 22, 2022

FOXI3 gene tied to craniofacial microsomia

June 22, 2022

COR-803 reduces SARS-CoV-2 viral load in vivo after oral treatment

June 22, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...